ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

sodium sulfate

Its studies are led by Norgine.

Drug pageSodium sulfate: every studyAll 5 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 3, since Oct 16, 20251 company-led study, 1 open or runningNext primary completion: Jan 6, 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Norgine11 open or runningphase 3since Oct 16, 2025Oct 16, 2025Jan 6, 2027phase 3 · NCT07218523

Also a collaborator on its studies: Parexel.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 16, 2025First study: phase 3 study in Bowel Cleansing Prior to Clinical ProceduresFirst studyNCT07218523 · 212 planned · Belgium, Croatia, Germany and more

Ahead

  1. Jan 6, 2027Primary completion: phase 3 study in Bowel Cleansing Prior to Clinical ProceduresNCT07218523

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 1 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07218523Bowel Cleansing Prior to Clinical Procedures · Belgium, Croatia, Germany and more3RecruitingJan 6, 2027212

How it is read

Names in the registry

  • “PLENVU®”, 1 entry

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.